Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

Trial Profile

Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs ANB 020 (Primary)
  • Indications Peanut hypersensitivity
  • Focus Adverse reactions; Proof of concept
  • Sponsors AnaptysBio
  • Most Recent Events

    • 26 Mar 2018 According to an AnaptysBio media release, Stephen Tilles is an investigator of this trial. The company plans to report detailed data from this trial at a future medical conference following study completion.
    • 26 Mar 2018 Interim results published in an AnaptysBio Media Release
    • 17 Feb 2018 According to an AnaptysBio media release, top-line data from this trial is expected in Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top